Treatment of vernal keratoconjunctivitis includes all except –
**Vernal Keratoconjunctivitis Management**
**Core Concept**
Vernal keratoconjunctivitis (VKC) is a chronic, allergic eye disease characterized by severe inflammation of the conjunctiva and cornea, typically affecting children and young adults. The condition is associated with elevated levels of IgE antibodies and the release of histamine and other mediators from mast cells.
**Why the Correct Answer is Right**
The management of VKC involves a combination of pharmacological and non-pharmacological interventions aimed at reducing inflammation, modulating the immune response, and alleviating symptoms. Topical corticosteroids, such as loteprednol and fluorometholone, are considered first-line treatment options, as they effectively reduce inflammation and prevent scarring. Mast cell stabilizers, like cromolyn sodium and nedocromil, are also used to prevent the release of histamine and other mediators from mast cells. In severe cases, immunosuppressive agents, such as cyclosporine, may be employed to modulate the immune response.
**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect as it is not a standard treatment for VKC. However, if this option is a treatment, then it would be incorrect if it was ineffective, or not used in this context.
* **Option B:** This option is incorrect as it is not a commonly used treatment for VKC. However, if this option is a treatment, then it would be incorrect if it was ineffective, or not used in this context.
* **Option C:** This option is incorrect as it is not a standard treatment for VKC. However, if this option is a treatment, then it would be incorrect if it was ineffective, or not used in this context.
* **Option D:** This option is incorrect as it is not a standard treatment for VKC. However, if this option is a treatment, then it would be incorrect if it was ineffective, or not used in this context.
**Clinical Pearl / High-Yield Fact**
It is essential to recognize that VKC often co-exists with other allergic conditions, such as asthma and atopic dermatitis, and that patients with VKC may require a comprehensive treatment plan that addresses all these conditions simultaneously.
**Correct Answer: D.**